Skip to main content
Epe pancreas


1. Lüthen, R., Owen, R.L., Sabria, M., Grendell, J.H. and Niederau, C.: Premature trypsin activation during cerulein pancreatitis in rats occurs inside pancreatic acinar cells. Pancreas, 17: 38-43, 1998.
2. Satoh, A., Shimosegawa, Kimura, K., Moriizumi, S., Masamune, Koizumi, M. and Toyota, T.: Nitric oxide is overproduced by peritoneal macrophages in rat taurocholate pancreatitis: the mechanism of inducible nitric oxide synthase expression. Pancreas, 17: 402-411, 1998.
3. Osman, M.O., Kristense, J.U., Jacobsen, N.O., Lausten, S.B., Deleuran, B., Deleuran, M., Gesser, B., Matsushima, K., Larsen, C.G. and Jensen, S.L.: A monoclonal anti-interleukin 8 antobody (WS-4) inhibitis cytokine response and acute lung injury in experimental severe acute necrotizing pancreatitis in rabbits. Gut, 43: 232-239, 1998.
4. Steer, M.L.: The early intraacinar cell events which occur during acute pancreatitis. Pancreas, 17: 31-37, 1998.
5. Van Laethem, J.L., Eskinazi, R., Louis, H., Robbrecht,P. and Deviere, J.: Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut, 43: 408-413, 1988.
6. Rivera, J.A., Werner, J., Warshaw, A.L., Lewandrowski, K.B., Rattner, D.W. and Fernandez-del Castillo, C.: Lexipafant fails to improve survival in severe necrotizing pancreatitis in rats. Int. J. Pancreatol., 23: 101-106, 1998.
7. Hofbauer, B., Saluja, A.L., Bhatia, M., Frossard, J.L., Lee, H.S., Bhagat, L. and Steer, M.: Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis. Gastroenterology, 115: 1238-1247, 1998.
8. Al-Mufti, R.A., Williamson, R.C.N. and Mathie, R.T.: Increased nitric oxide activity in a rat model of acute pancreatitis. Gut, 43: 564-570, 1998.
9. Neoptolemos, J.P., Raraty, M., Finch, M. and Sutton, R.: Acute pancreatitis: the substantial human and financial costs. Gut, 42: 886-891, 1998.
10. Appelros, S., Thim, L. and Borgstöm, A.: Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis. Gut, 42: 97-102, 1998.
Epehólyag, epeútak és pancreas – gastroenterologia – Takács Tamás
11. Büchler, M.W., Uhl, W. and Andren-Sandberg, A.: CAPAP in acute pancreatitis: just another marker or real progress? Gut, 42: 8-10, 1998.
12. Rau, B., Steinbach, G., Gansauge, F., Mayer, J.M., Grünert, A. and Beger, H.G.: The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut, 41: 832-840, 1997.
13. Brunkhorst, F.M., Eberhard, O.K. and Brunkhorst, R.: Early identification of biliary pancreatitis with procalcitonin. Am. J. Gastroenterol., 93: 1191-1192, 1998.
14. Tsai, C.J.: Is obesity a significant prognostic factor in acute pancreatitis? Dig. Dis. Sci., 43: 2251-2254, 1998.
15. Kalfarentzos, F., Kehagias, J., Mead, N., Kokkinis, K. and Gogos, C.A.: Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br. J. Surg., 84: 1665-1669, 1997.
16. Nakad, A., Piessevaux, H., Marot, A.C., Hoang, P., Geubel, A., Van Sternbergen, W. and Reznaert, M.: Is enteral nutrition in acute pancreatitis dangerous? About 2 patients fed by an endoscopically placed nasogastrojejunal tube. Pancreas, 17: 187-193, 1998.
17. Hamvas J. és Pap Á.: A jejunális táplálás szerepe az akut nekrotizáló pancreatitis és a krónikus pancreatitis súlyos nekrózissal járó recidíváinak kezelésében. Orv. Hetil., 139: 945-949, 1998.
18. Freedman, S.D.: New concepts in understanding the pathophysiology of chronic pancreatitis. Int. J. Pancreatol., 24: 1-8, 1998.
19. DiMagno, E.P.: A perspective of the use of tubeless pancreatic tubeless tests in diagnosis. Gut, 43: 2-3, 1998.
20. Lankisch, P.G., Schmidt, I., König, H., Lehnick, D., Knollmann, P., Löhr, M. and Liebe, S.: Fecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut, 42: 551-554, 1998.
21. Nakamura, T., Takeuchi, T. and Tando, Y.: Pancreatic dysfunction and treatment options. Pancreas, 16: 329-336, 1998.
Epehólyag, epeútak és pancreas – gastroenterologia – Takács Tamás
22. Carmen Garces, M., Gomez-Cerezo, J., Alba, D., Codeceo, R., Vazquez-Munoz, E., Arnalich, F., Barbado, F.J. and Vazquez, J.J.: Relationship of basal and postprandial intraduodenal bile acid concentrations and plasma cholecystokinin levels with abdominal pain in patients with chronic pancreatitis. Pancreas, 17: 397-401, 1998.
23. Friess, H., Kleeff, J., Isenmann, R., Malfertheiner, P. and Büchler, M.: Adaptation of the human pancreas to inhibition of luminal proteolytic activity. Gastroenterology, 115: 388-396, 1998.
24. Bramhall, S.R.: The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis. Int. J. Pancreatol., 23: 83-100, 1998.
25. Dugan, M.C., and Sarkar, F.H.: Current concept of pancreatic cancer: symposium summary. Pancreas, 17: 325-333, 1998.
26. Joshi, U.S., Dergham, S.T., Chen, Y., Dugan, M.C., Crissmann, J.D., Vaitkevicius, V.K. and Sarkar, F.H.: Inhibition of tumor cell growth in culture by p21WAF1 recombinant
adenovirus. Pancreas, 16: 107-113, 1998.
27. Mohammad, R.M., Dugan, M.C., Mohamed, A.N.: Establishment of human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents. Pancreas, 16: 19-25, 1998.